Srivastava S, Painuly N K, Mishra S P, Srivastava K, Singh N, Singh S, Bhatt M L B
MSc, Assistant Professor, Department of Radiotherapy, King George's Medical University,Lucknow, Uttar Pradesh, India.
PhD, Professor of Medical Physics, Department of Radiotherapy King George's Medical University, Lucknow, Uttar Pradesh, India.
J Biomed Phys Eng. 2019 Dec 1;9(6):603-612. doi: 10.31661/jbpe.v0i0.867. eCollection 2019 Dec.
Brachytherapy treatment planning in cervix carcinoma patients using two dimensional (2D) orthogonal images provides only point dose estimates while CT-based planning provides volumetric dose assessment helping in understanding the correlation between morbidity and the dose to organs at risk (OARs) and treatment volume.
Aim of present study is to compare International Commission on Radiation Units and Measurements Report 38 (ICRU 38) reference point doses to OARs with volumetric doses using 2D images and CT images in patients with cervical cancer.
In this prospective study, 20 patients with cervical cancer stages (IIB-IIIB) were planned for a brachytherapy dose of 7Gy per fraction for three fractions using 2D image-based treatment plan and CT-based plan. ICRU 38 points for bladder and rectum were identified on both 2D image-based plan and CT-based plan and doses (D) at these points were compared to the minimum dose to 2cc volume (D) of bladder and rectum receiving the highest dose.
D bladder dose was 1.60 (±0.67) times more than D bladder dose whereas D rectum dose was 1.13±0.40 times D. Significant difference was found between D and D dose for bladder (p=.0.016) while no significant difference was seen between D and D dose for rectum (p=0.964).
The study suggests that ICRU 38 point doses are not the true representation of maximum doses to OARs. CT-based treatment planning is more a reliable tool for OAR dose assessment than the conventional 2D radiograph-based plan.
宫颈癌患者使用二维(2D)正交图像进行近距离放射治疗计划时,仅提供点剂量估计,而基于CT的计划可提供体积剂量评估,有助于理解发病率与危及器官(OARs)剂量及治疗体积之间的相关性。
本研究的目的是比较宫颈癌患者使用2D图像和CT图像时,国际辐射单位与测量委员会第38号报告(ICRU 38)中OARs参考点剂量与体积剂量。
在这项前瞻性研究中,20例宫颈癌(IIB-IIIB期)患者计划采用基于2D图像的治疗计划和基于CT的计划,进行每次7Gy、共三次分割的近距离放射治疗。在基于2D图像的计划和基于CT的计划上均确定膀胱和直肠的ICRU 38点,并将这些点的剂量(D)与接受最高剂量的膀胱和直肠2cc体积的最小剂量(D)进行比较。
膀胱D剂量比膀胱D剂量高1.60(±0.67)倍,而直肠D剂量是D的1.13±0.40倍。膀胱D与D剂量之间存在显著差异(p = 0.016),而直肠D与D剂量之间无显著差异(p = 0.964)。
该研究表明,ICRU 38点剂量并非OARs最大剂量的真实代表。基于CT的治疗计划比传统的基于2D射线照片的计划更可靠,是OAR剂量评估的工具。